Experimental drug can reverse osteoarthritis in weeks, animal research shows

Exciting animal research reveals an experimental drug can reverse osteoarthritis in just weeks! This potential breakthrough could offer new hope and a future free from pain for many. 💊 #OsteoarthritisResearch #MedicalNews #Hope

Oxidative Balance Score and Osteoarthritis: A Multi-Omics Study Based on NHANES, RNA-seq, and Mendelian Randomization
Hu, Y., Liu, T. et al.
Paper
Details
#OxidativeBalance #OsteoarthritisResearch #MultiOmicsStudy

Identification of Key Chondrocyte Apoptosis-Related Genes in Osteoarthritis Based on Weighted Gene Co-Expression Network Analysis and Experimental Verification

www.dl.begellhouse.com/journals/2ff...

#OsteoarthritisResearch #Bioinformatics #GeneExpression

Circulating miR-126-3p is a mechanistic biomarker for knee osteoarthritis | Nature Communications Osteoarthritis is a major contributor to pain and disability worldwide, yet there are currently no validated soluble biomarkers or disease-modifying treatments. Given that microRNAs are promising mechanistic biomarkers that can be therapeutically targeted, in this study, we aimed to identify and prioritize reproducible circulating microRNAs associated with radiographic knee osteoarthritis. Across four independent cohorts, we find circulating miR-126-3p is elevated in knee osteoarthritis versus controls. Across six primary human knee osteoarthritis tissues, miR-126-3p is highest in subchondral bone, fat pad and synovium, and lowest in cartilage. Following both intravenous and intra-articular miR-126-3p mimic treatment in a surgical mouse model of knee osteoarthritis, we show reduced disease severity in males. In human knee osteoarthritis biospecimens, miR-126-3p mimic treatment reduces genes and markers associated with angiogenesis, as well as genes linked to osteogenesis, adipogenesis,

Circulating miR-126-3p is elevated in knee osteoarthritis across 4 cohorts! A promising mechanistic biomarker for the disease. #OsteoarthritisResearch PMID:40016267, Nat Commun 2025, @NatureComms https://doi.org/10.1038/s41467-025-57308-5 #Medsky #Pharmsky #RNA 🧪